modified GRF(1-29) is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Updated 2026-03-01. Numbers and descriptions here follow the published literature rather than marketing material.
The compound emerged from work at a Canadian biotechnology firm in the early 2000s. Early human studies examined its effect on growth hormone and insulin-like growth factor 1 in healthy volunteers and in people with HIV-associated fat redistribution. Reports described sustained increases in both markers after a single injection. Development did not advance to regulatory approval, and the clinical programme was later discontinued. The molecule is now encountered mainly as a research chemical rather than a marketed medicine.
Two forms circulate in research settings and are frequently confused. One carries the drug affinity complex and is often written as CJC-1295 with DAC; the other lacks that group and is usually called modified GRF(1-29). The two share the same core sequence but differ sharply in how long they persist in blood. Products labelled only as CJC-1295 normally refer to the version carrying the complex. Documentation that omits the distinction leaves the intended molecule ambiguous.
CJC-1295 is a synthetic peptide built as a long-acting analogue of growth hormone-releasing hormone. Its backbone matches the first twenty-nine residues of the natural human hormone, with four amino acid substitutions added to slow enzymatic breakdown. A reactive maleimide group, commonly termed the drug affinity complex, allows the peptide to attach to circulating albumin after administration. That albumin attachment keeps the molecule in the bloodstream for an extended period instead of being cleared within minutes.
Peptide degradation proceeds mainly through hydrolysis, oxidation of methionine, and deamidation of asparagine or glutamine residues. The maleimide group on the albumin-binding variant can also react with thiols or hydrolyze in aqueous media. Because these pathways accelerate with temperature and pH extremes, handling conditions strongly influence measured stability. Stability data in the public literature are limited and often generated under differing conditions, so general statements about shelf life should be read as approximate.
Research material is normally supplied as a freeze-dried powder in sealed vials. In that state the peptide is comparatively robust, but prolonged exposure to warmth, moisture, or light accelerates degradation. Storage at minus twenty degrees Celsius or lower, with desiccant and protection from light, is the commonly described practice. Vials should be allowed to reach room temperature before opening to limit condensation on the powder. Moisture uptake during handling is a recognized source of variability in later measurements.
Reconstitution is typically performed with sterile water or bacteriostatic water, added slowly against the vial wall. The resulting solution should be clear and colorless; cloudiness or visible particles suggest a problem with the material or the diluent. Once in solution, the peptide is less stable than the dry powder. Refrigerated storage at two to eight degrees Celsius is common for short-term holding, while freezing aliquots is described for longer periods.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C152H252N44O42 | Cited for the form without the drug affinity complex |
| Molecular weight | About 3368 Da | Reported value for modified GRF(1-29) |
| Appearance | White to off-white powder | Lyophilised solid as usually supplied |
| Solubility | Soluble in water and polar solvents | Clarity depends on purity and salt content |
| Typical storage | -20 C or below, dry | Protect from light and repeated warming cycles |
4-HO-DPT acts as a high-efficacy partial agonist to full agonist of the serotonin 5-HT2A, 5-HT2B, and 5-HT2C receptors. It has more than two orders of magnitude greater potency as an agonist of the serotonin 5-HT2A and 5-HT2B receptors than as an agonist of the serotonin 5-HT2C receptor. Hence, it shows considerable selectivity for the serotonin 5-HT2A receptor over the serotonin 5-HT2C receptor. Compared to psilocin (4-HO-DMT), 4-HO-DPT has about the same potency and efficacy as a serotonin 5-HT2A receptor agonist, has about the same potency but is much more efficacious as a serotonin 5-HT2B receptor agonist (EmaxTooltip maximal efficacy = 39% vs. 94%, respectively), and has about the same efficacy but approximately 10-fold lower potency as a serotonin 5-HT2C receptor agonist. 4-HO-DPT produces the head-twitch response, a behavioral proxy of psychedelic effects, in rodents. Its potency for inducing the head-twitch response in mice is about 4- or 5-fold lower than that of psilocin.
MetService issues red-level wind warnings for the Canterbury and Wellington Regions and the Wairarapa south of Carterton. Emergency Management and Recovery Minister Mark Mitchell declares a local state of emergency in Canterbury in response to strong winds and fires. Parliament passes legislation limiting the threshold for Māori foreshore and seabed claims. While government parties supported the legislation, opposition parties vowed to repeal the law change. In response, Te Pāti Māori MPs Debbie Ngarewa-Packer and Tākuta Ferris burnt a copy of the legislation in protest. 23 October – Five unions (the Public Service Association, the New Zealand Educational Institute, the Post Primary Teachers' Association, the New Zealand Nurses Organisation, and the Association of Salaried Medical Specialists) hold a coordinated national strike. Due to severe wind storms nationwide, several protest events in the South Island were cancelled or moved indoors. 24 October: Emergency Management Minister Mark Mitchell declares a state of local emergency for the Southland Region in response to wind and storm damage. The Clutha District Council declares a state of emergency in the Clutha District in response to wind and storm damage. The state of emergency had been lifted for much of Canterbury except the Kaikoura District. Health New Zealand confirms that a recent measles community outbreak was linked to a Northland patient who travelled aboard a Bluebridge ferry across the Cook Strait on 3 October, bringing the total number of measles cases nationwide to eight.
It includes the midbrain, pons, and medulla oblongata and regulates essential functions such as breathing, heart rate, and sleep. Brain ventricles A set of interconnected cavities within the brain that produce and circulate cerebrospinal fluid (CSF). Includes the lateral, third, and fourth ventricles. Brain waves Patterns of electrical activity in the brain, typically detected by electroencephalography (EEG). Brain waves are categorized by frequency, such as alpha, beta, delta, and theta waves. Brain-computer interface (BCI) A technology that enables direct communication between the brain and an external device, often used in research, prosthetics, and communication aids for individuals with disabilities. Bradykinesia Slowness of movement, often a symptom of Parkinson’s disease and other disorders involving the basal ganglia. Broca's area A region in the frontal lobe, typically in the left hemisphere, associated with the production of speech. Damage can result in Broca's aphasia, characterized by impaired speech fluency. Broca's aphasia A language disorder caused by damage to Broca's area, resulting in slow, laborious speech with relatively preserved comprehension. Brodmann areas Regions of the cerebral cortex defined by Korbinian Brodmann based on cytoarchitecture. These areas are still widely used to describe functional brain localization (e.g., Brodmann area 17 = primary visual cortex). Burst firing A pattern of rapid spikes from a neuron followed by a period of quiescence. It plays a role in sensory encoding and signal amplification in various brain circuits.
== Signs and symptoms == Common symptoms of obstructive sleep disorder syndrome include unexplained daytime sleepiness, restless sleep, frequent awakenings and loud snoring (with periods of silence followed by gasps). Less common symptoms are morning headaches; insomnia; trouble concentrating; mood changes such as irritability, anxiety, and depression; bruxism (teeth grinding), forgetfulness; increased heart rate or blood pressure; erectile dysfunction, unexplained weight gain; increased urinary frequency or nocturia; frequent heartburn or gastroesophageal reflux; and heavy night sweats. Many people experience episodes of OSA transiently, for only a short period. This can be the result of an upper respiratory infection that causes nasal congestion, swelling of the throat, or tonsillitis that temporarily produces very enlarged tonsils. The Epstein-Barr virus, for example, is known to be able to increase the size of lymphoid tissue dramatically during acute infection, and OSA is fairly common in acute cases of severe infectious mononucleosis. Temporary spells of OSA syndrome may also occur in people who are under the influence of a drug (such as alcohol) that may relax their body tone excessively and interfere with normal arousal from sleep mechanisms.
== External links == JPL Develops High-Speed Test to Improve Pathogen Decontamination at the Wayback Machine (archived 2016-03-04) at JPL. Spotting Spores at the Wayback Machine (archived 2016-03-04) at Astrobiology Magazine.
Sources: en.wikipedia.org
== Clinical trials == Sulanemadlin is notable as the first stapled peptide, a novel pharmaceutical strategy, to enter clinical trials. Despite its preclinical promise, concerns about side effects, including severe neutropenia, have terminated Phase 1B clinical trials early in at least one trial.
== Biography == He is a member of the editorial board of the journal Intelligence. His PhD was completed in 1994 at the University of Auckland (New Zealand) and integrated the Eysenckian dimensional model of psychosis with the categorical model of schizotypy proposed by Paul E. Meehl, using measures of personality, creativity, evoked potentials, and smooth pursuit eye movement dysfunction. The title of his doctoral thesis was Psychometric & psychophysiological measures for schizotypy, creativity & psychoticism. Subsequent academic publications include demonstrating the existence of two separate forms of dyslexia, underpinned by distinct genes, and, subsequently, demonstrating that the genes associated with dyslexia are also linked to normal variation in reading ability. This work lead to searches for specific genes involved in reading and language. In positive psychology, he showed (along with Alexander Weiss and Michelle Luciano) that the genes for happiness are genes for personality, suggesting that a general factor of genetic well-being and specific genetic influences from the five factor model traits of Extraversion, Neuroticism/Stability, and Conscientiousness completely explain the heritable component of differences in happiness. With Caroline Rae, Bates showed that creatine supports cognitive function – finding that creatine supplements in vegans substantially increased their cognitive ability and working memory by comparison with placebo. This supported a literal 'mental energy' model of intelligence, first postulated by Charles Spearman.
Beyond the right of free movement to work, the EU has increasingly sought to guarantee rights of citizens, and rights simply be being a human being. But although the Court of Justice stated that 'Citizenship is destined to be the fundamental status of nationals of the Member States', political debate remains on who should have access to public services and welfare systems funded by taxation. As of now, Union citizenship is criticised for being not inclusive enough and having failed to establish a truly borderless space of social solidarity. In 2008, just 8 million people from 500 million EU citizens (1.7 per cent) had in fact exercised rights of free movement, the vast majority workers. According to TFEU article 20, citizenship of the EU derives from nationality of a member state. Article 21 confers general rights to free movement in the EU and to reside freely within limits set by legislation. This applies for citizens and their immediate family members. This triggers four main groups of rights: (1) to enter, depart and return, without undue restrictions, (2) to reside, without becoming an unreasonable burden on social assistance, (3) to vote in local and European elections, and (4) the right to equal treatment with nationals of the host state, but for social assistance only after 3 months of residence.
The second presidency of Luiz Inácio Lula da Silva, also known as Lula's third government, began on 1 January 2023, when Luiz Inácio Lula da Silva returned to office for a third term as President of Brazil. A member of the Workers' Party (PT), Lula was elected in the second round of the 2022 presidential election, defeating incumbent president Jair Bolsonaro. He became the first Brazilian president to be elected to three terms and the first since Getúlio Vargas to return to the presidency after an interval between terms. The administration took office amid deep political polarization and the aftermath of the 2022–2023 Brazilian coup attempt, with the 8 January attacks on Brazil's government institutions constituting one of its first major political crises. The administration has been characterized by the restoration and expansion of social and public policies, changes to Brazil's fiscal and tax framework, and efforts to strengthen the role of the federal government. Major economic measures included the approval of a consumption tax reform and the replacement of the previous spending cap with a new fiscal framework. The government recorded periods of economic growth and declining unemployment, while facing concerns over public debt, fiscal sustainability, interest rates, household indebtedness, corporate financial difficulties, and the rising cost of living, particularly food prices.
=== NOP cellular signalling partners === Like most G-protein coupled receptors, NOP signals through canonical G proteins upon activation. G proteins are heterotrimeric complexes consisting of α, β, and γ subunits. NOP signals through a variety of Gα subtypes that trigger diverse downstream signaling cascades. NOP coupling to Gαi or Gαo subunits leads to an inhibition of adenylyl cyclase (AC) causing an intracellular decrease in cyclic adenosine monophosphate(cAMP) levels, an important second messenger for many signal transduction pathways. NOP acting through Gαi/o pathways has also been shown to activate Phospholipase A2 (PLA2), thereby initiating Mitogen-activated protein kinase (MAPK) signaling cascades. In contrast to classical OPs, NOP also couples to Pertussis toxin (PTX)-insensitive subtypes Gαz, Gα14, and Gα16, as well as potentially to Gα12 and Gαs. Activation of NOP's canonical β-arrestin pathway causes receptor phosphorylation, internalization, and eventual downregulation and recycling. NOP activation also causes indirect inhibition of opioid receptors MOP and KOP, resulting in anti-opioid activity in certain tissues. Additionally, NOP activation leads to the activation of potassium channels and inhibition of calcium channels which collectively inhibit neuronal firing.
Sources: en.wikipedia.org
It is a synthetic peptide analogue of growth hormone-releasing hormone. Four substitutions in its sequence make it more resistant to enzymatic degradation than the natural hormone. In the version carrying a drug affinity complex, the peptide binds albumin and remains in circulation for days.
No regulatory agency has approved CJC-1295 for clinical use. Human trials were conducted in the 2000s, but the development programme was discontinued before any marketing application succeeded. Material sold today is offered as a research chemical, and its purity depends on the supplier.
Sermorelin is an unmodified fragment of growth hormone-releasing hormone and is cleared quickly. CJC-1295 contains substitutions that resist breakdown, and the form with a drug affinity complex persists much longer. Both act at the same receptor but differ substantially in duration of action.
Cool, dark, and dry conditions are standard, with storage at minus twenty degrees Celsius or below. Desiccant and sealed vials limit moisture uptake. Repeated warming and cooling of the container is generally avoided.